Repeated Lipopolysaccharide (LPS) or Cytokine Treatments Sensitize Ethanol Withdrawal-Induced Anxiety-Like Behavior
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 89 of the 90 references it cites were found in a registry or an index.
Abstract
Previous investigations demonstrated that repeated stresses before an ethanol exposure sensitize ethanol withdrawal-induced anxiety-like behavior ('anxiety'). In addition to activating the hypothalamic-pituitary-adrenal axis, acute stress also elevates cytokines in brain. Initially, to test possible cytokine involvement in this stress/withdrawal protocol, cytokines were increased in brain with 2 weekly repeated lipopolysaccharide (LPS) administrations (1000 microg/kg) [corrected] (LPS/withdrawal protocol) or with twice weekly intracerebroventricular (i.c.v.) administrations of the cytokines IL-1 beta, CCL2 (MCP-1) or TNFalpha (cytokine/withdrawal protocol) before exposure and withdrawal from a 5-day cycle of chronic ethanol diet. Both protocols sensitized withdrawal-induced anxiety and confirm cytokine involvement in the sensitized anxiety response. Testing of various doses of LPS (16-1000 microg/kg) and TNFalpha (3-100 ng, i.c.v.) demonstrated the dose-related nature of these protocols to sensitize withdrawal-induced anxiety. The sensitized anxiety was not produced by a single 5-day ethanol diet cycle or by repeated LPS or cytokine treatments alone. Likewise, sensitized anxiety in these protocols could not be attributed to differences in ethanol ingestion. When challenged with a subsequent re-exposure to a 5-day ethanol diet cycle 16 days after completion of the LPS/withdrawal or cytokine/withdrawal protocols, an increase in withdrawal-induced anxiety was observed-an indication of induction of an underlying persistent adaptive change. Finally, just as found previously with the stress/withdrawal protocol, administration of the benzodiazepine receptor antagonist flumazenil before the LPS or TNF treatments prevented anxiety sensitization. Together, these findings indicate that increased cytokine activity induces adaptive change that supports sensitization of ethanol withdrawal-induced anxiety that may be linked to GABA(A)-receptor function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Injections of TNFa in the amygdala in rats increased anxiety-like behavior and mimicked the amplification of anxiety-like behavior that was observed with repeated cycles of alcohol drinking (Breese et al., 2008).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Breese et al., 2008
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“One overlapping aspect of acute stress (Carrasco and Van de Kar, 2003; Vale et al, 1981; Rivest and Rivier, 1994) and acute ethanol (Rivier et al, 1984; Rivier, 1996) is an effect on the hypothalamic– pituitary–adrenal (HPA) axis.”
BackgroundVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · cited 1×
“These findings led to the hypothesis that cytokines are involved in depressive illness (Anisman and Merali, 2003; Dunn et al, 2005; Hayley et al, 2005; Raison et al, 2006; Simen et al, 2006) and addictive behavior (Crews et al, 2006; Friedman and Eisenstein, 2004).”
BackgroundHow does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504 · cited 3×
“Although early studies implicated cytokines in the release of CRF and HPA axis activation (Berkenbosch et al, 1987; Sapolsky et al, 1987; Takemura et al, 1997; Turnbull et al, 1997; see review in Turnbull and Rivier, 1995, 1999a, b), the possibility that cytokines might be involved in the adaptive…”
BackgroundRegulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action
TURNBULL, A. V., & RIVIER, C. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.1 · Cited by 1,297 · cited 2×
“…including ‘sickness behavior’ (Kent et al, 1992; Bluthe et al, 1992; Fiore et al, 1998), fever, altered emotional behavior (Anisman and Merali, 2003; Yamada et al, 2000), and changes in endocrine function (Connor et al, 1998; Dunn et al, 2005; Turnbull and Rivier, 1999a, b; Watkins et al, 1995).”
BackgroundCorticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151 · cited 1×
“Although early studies implicated cytokines in the release of CRF and HPA axis activation (Berkenbosch et al, 1987; Sapolsky et al, 1987; Takemura et al, 1997; Turnbull et al, 1997; see review in Turnbull and Rivier, 1995, 1999a, b), the possibility that cytokines might be involved in the adaptive…”
BackgroundThe neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965 · cited 2×
“…of cytokines in these acute symptoms, cytokines may be involved in symptoms of depressive illness and negative affect (Anisman and Merali, 1999, 2003; Bonaccorso et al, 2003; Dunn et al, 2005; Millan, 2003; Pucak and Kaplin, 2005; Smith, 1991) and addictive behavior (Friedman and Eisenstein, 2004).”
BackgroundThe macrophage theory of depression
Smith, R. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90272-z · Cited by 931 · cited 2×
“…of cytokines in these acute symptoms, cytokines may be involved in symptoms of depressive illness and negative affect (Anisman and Merali, 1999, 2003; Bonaccorso et al, 2003; Dunn et al, 2005; Millan, 2003; Pucak and Kaplin, 2005; Smith, 1991) and addictive behavior (Friedman and Eisenstein, 2004).”
Background
Cited by
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“Injections of TNFa in the amygdala in rats increased anxiety-like behavior and mimicked the amplification of anxiety-like behavior that was observed with repeated cycles of alcohol drinking (Breese et al., 2008).”
The role of neuroimmune signaling in alcoholism
Crews, F. T., Lawrimore, C. J., Walter, T. J., & Coleman, L. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.031 · Cited by 321
Induction of innate immune genes in brain create the neurobiology of addiction
Crews, F. T., Zou, J., & Qin, L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.03.003 · Cited by 313
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
Koob, G. F., & Colrain, I. M. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0446-0 · Cited by 276
Breese, G. R., Sinha, R., & Heilig, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.007 · Cited by 261
“Given these observations, the possibility is likely that cytokines released by stress contribute to the mediation of stress sensitization of alcohol withdrawal-induced symptoms (Breese et al., 2008).”
BackgroundMethodInfluentialSelf-citationPascual, M., Baliño, P., Alfonso-Loeches, S., Aragón, C. M. G., & Guerri, C. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.012 · Cited by 213
“Accordingly, Breese et al., 2008 demonstrated that repeated LPS or TNF-a treatments sensitize ethanol withdrawal-induced anxiety-like behavior.”
BackgroundResultPascual, M., Baliño, P., Aragón, C. M. G., & Guerri, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.014 · Cited by 200
Toll-like receptor signaling and stages of addiction
Crews, F. T., Walter, T. J., Coleman, L. G., & Vetreno, R. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4560-6 · Cited by 156
Liu, J., Yang, A. R., Kelly, T., Puche, A., Esoga, C., June, H. L., Elnabawi, A., Merchenthaler, I., Sieghart, W., June, H. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019020108 · Cited by 152
Stopponi, S., Somaini, L., Cippitelli, A., Cannella, N., Braconi, S., Kallupi, M., Ruggeri, B., Heilig, M. A., Demopulos, G. A., Gaitanaris, G., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.010 · Cited by 139
Antón, M., Alén, F., Gómez de Heras, R., Serrano, A., Pavón, F. J., Leza, J. C., García‐Bueno, B., Rodríguez de Fonseca, F., & Orio, L. (2017) · Addiction Biology · doi:10.1111/adb.12365 · Cited by 123
Davis, D. J., Hecht, P. M., Jasarevic, E., Beversdorf, D. Q., Will, M. J., Fritsche, K., & Gillespie, C. H. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.09.003 · Cited by 112
Rathbone, A. T. L., Tharmaradinam, S., Jiang, S., Rathbone, M. P., & Kumbhare, D. A. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.009 · Cited by 109
Innate Immune Signaling and Alcohol Use Disorders
Coleman, L. G., & Crews, F. T. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_92 · Cited by 107
Rat animal models for screening medications to treat alcohol use disorders
Bell, R. L., Hauser, S. R., Liang, T., Sari, Y., Maldonado‐Devincci, A. M., & Rodd, Z. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.004 · Cited by 101
“…the adrenergic (Rasmussen et al., 2014), corticotrophin (Overstreet et al., 2007), dopaminergic (Overstreet et al., 2007), GABAergic (GABRA-BDZ: Knapp et al., 2007a, 2007b), neuroimmune (Breese et al., 2008), Table 7 Rat studies on alcohol-seeking behavior and its pharmacological disruption.”
BackgroundFinn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 101
“…Savastano et al., 1994; Torpy and Chrousos, 1996; Turnbull and Rivier, 1999), anxiety- and depression-related behaviour (Anisman and Merali, 1999; Breese et al., 2008; Connor and Leonard, 1998; Craddock and Thomas, 2006; Leonard, 2001; Leonard, 2006; Nautiyal et al., 2008; O'Brien et al., 2004;…”
Alcohol, microbiome, and their effect on psychiatric disorders
Hillemacher, T., Bachmann, O., Kahl, K. G., & Frieling, H. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.015 · Cited by 87
Doremus‐Fitzwater, T. L., Buck, H. M., Bordner, K., Richey, L., Jones, M. E., & Deak, T. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12481 · Cited by 85
Whitman, B. A., Knapp, D. J., Werner, D. F., Crews, F. T., & Breese, G. R. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12189 · Cited by 79
Self-citationPotential of Glial Cell Modulators in the Management of Substance Use Disorders
Jones, J. D. (2020) · CNS Drugs · doi:10.1007/s40263-020-00721-9 · Cited by 79
Alcohol and Stress Activation of Microglia and Neurons: Brain Regional Effects
Walter, T. J., Vetreno, R. P., & Crews, F. T. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13511 · Cited by 75
Stopponi, S., de Guglielmo, G., Somaini, L., Cippitelli, A., Cannella, N., Kallupi, M., Ubaldi, M., Heilig, M., Demopulos, G., Gaitanaris, G., et al. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12091 · Cited by 74
“, anxiety) signs of alcohol withdrawal has also been established (Breese et al., 2008).”
BackgroundPatel, R. R., Khom, S., Steinman, M. Q., Varodayan, F. P., Kiosses, W. B., Hedges, D. M., Vlkolinsky, R., Nadav, T., Polis, I., Bajo, M., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.10.009 · Cited by 70
Xu, J., Ma, H.-Y., Liu, X., Rosenthal, S., Baglieri, J., McCubbin, R., Sun, M., Koyama, Y., Geoffroy, C. G., Saijo, K., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.131277 · Cited by 66
Ethanol and Cytokines in the Central Nervous System
Roberto, M., Patel, R. R., & Bajo, M. (2017) · Handbook of experimental pharmacology · doi:10.1007/164_2017_77 · Cited by 76
Nakatani-Pawlak, A., Yamaguchi, K., Tatsumi, Y., Mizoguchi, H., & Yoneda, Y. (2009) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.32.1576 · Cited by 61
Ethanol Consumption in Mice Lacking CD14, TLR2, TLR4, or MyD88
Blednov, Y. A., Black, M., Chernis, J., Da Costa, A., Mayfield, J., & Harris, R. A. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13316 · Cited by 61
Knapp, D. J., Whitman, B. A., Wills, T. A., Angel, R. A., Overstreet, D. H., Criswell, H. E., Ming, Z., & Breese, G. R. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.018 · Cited by 60
Self-citationEssential role of interleukin-15 receptor in normal anxiety behavior
Wu, X., He, Y., Hsuchou, H., Kastin, A. J., Rood, J. C., & Pan, W. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.06.012 · Cited by 58
Freeman, K., Brureau, A., Vadigepalli, R., Staehle, M. M., Brureau, M. M., Gonye, G. E., Hoek, J. B., Hooper, D. C., & Schwaber, J. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-97 · Cited by 57
Immune treatments for alcohol use disorder: A translational framework
Meredith, L. R., Burnette, E. M., Grodin, E. N., Irwin, M. R., & Ray, L. A. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.07.023 · Cited by 56
Hung, Y.-Y., Lin, C.-C., Kang, H., & Huang, T. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.09.014 · Cited by 58
IL-1 interacts with ethanol effects on GABAergic transmission in the mouse central amygdala
Bajo, M., Varodayan, F. P., Madamba, S. G., Robert, A. J., Casal, L. M., Oleata, C. S., Siggins, G. R., & Roberto, M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00049 · Cited by 53
Addiction, Adolescence, and Innate Immune Gene Induction
Crews, F. T., & Vetreno, R. P. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00019 · Cited by 52
Immune function genes, genetics, and the neurobiology of addiction
Crews, F. T. (2012) · Alcohol research · doi:10.35946/arcr.v34.3.11 · Cited by 62
Choubey, P., Kwatra, M., Pandey, S. N., Kumar, D., Dwivedi, D. K., Rajput, P., Mishra, A., Lahkar, M., & Jangra, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5105-3 · Cited by 53
Vetreno, R. P., Qin, L., Coleman, L. G., & Crews, F. T. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14669 · Cited by 52
Substance use disorders: Psychoneuroimmunological mechanisms and new targets for therapy
Loftis, J. M., & Huckans, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.011 · Cited by 47
Nelson, T. E., Hao, C., Manos, J., Ransohoff, R. M., & Gruol, D. L. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.02.013 · Cited by 47
Díaz, L. A., Winder, G. S., Leggio, L., Bajaj, J. S., Bataller, R. A., & Arab, J. P. (2025) · Hepatology · doi:10.1097/hep.0000000000000645 · Cited by 49
Knapp, D. J., Harper, K. M., Whitman, B. A., Zimomra, Z. R., & Breese, G. R. (2016) · Brain Sciences · doi:10.3390/brainsci6030025 · Cited by 48
Self-citationKoob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 54
Valenta, J. P., & Gonzales, R. A. (2016) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12928 · Cited by 36
Karlsson, C., Schank, J. R., Rehman, F., Stojakovic, A., Björk, K., Barbier, E., Solomon, M. G., Tapocik, J. D., Engblom, D., Thorsell, A., et al. (2016) · Addiction Biology · doi:10.1111/adb.12416 · Cited by 38
Li, Z., Vidjro, O. E., Guo, G., Du, Y., Zhou, Y., Xie, Q., Li, J., Gao, K., Zhou, L., & Ma, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02666-w · Cited by 38
“Breese’s research confirmed that IL-1β and TNF-α are involved in the sensitized anxiety response caused by repeated alcohol withdrawal [36].”
BackgroundKnapp, D. J., Overstreet, D. H., Angel, R. A., Navarro, M., & Breese, G. R. (2007) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00514.x · Cited by 39
Self-citationMonnig, M. A. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1211667 · Cited by 38
Tyler, R. E., Kim, S. W., Guo, M., Jang, Y. J., Damadzic, R., Stodden, T., Vendruscolo, L. F., Koob, G. F., Wang, G., Wiers, C. E., et al. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14392 · Cited by 36
“Evidence suggests that neuroimmune responses to alcohol may contribute to alcohol consumption (Marshall, Casachahua, et al., 2016; Obernier, White, Swartzwelder, & Crews, 2002), craving (Northcutt et al., 2015), and negative affect during withdrawal (Breese et al., 2008).”
BackgroundThe role of Toll-like receptors in neurobiology of alcoholism
Airapetov, M. I., Eresko, S. O., Aa, L., Бычков, Э. Р., & Shabanov, P. D. (2021) · BioScience Trends · doi:10.5582/bst.2021.01041 · Cited by 33
Patel, R. R., Varodayan, F. P., Herman, M. A., Jiménez, V., Agnore, R., Gao, L., Bajo, M., Carlson, V. C. C., Walter, N. A. R., Fei, S. S., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01231-y · Cited by 29
Covid-19 interface with drug misuse and substance use disorders
Cisneros, I. E., & Cunningham, K. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108766 · Cited by 33
Baxter-Potter, L. N., Henricks, A. M., Berger, A. L., Bieniasz, K. V., Lugo, J. M., & McLaughlin, R. J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.015 · Cited by 32
Tumour Necrosis Factor in Neuroplasticity, Neurogenesis and Alcohol Use Disorder
Cooper, I. A., Beecher, K., Chehrehasa, F., Belmer, A., & Bartlett, S. E. (2020) · Brain Plasticity · doi:10.3233/bpl-190095 · Cited by 36
Ethanol induces interferon expression in neurons via TRAIL: role of astrocyte-to-neuron signaling
Lawrimore, C. J., Coleman, L. G., & Crews, F. T. (2019) · Psychopharmacology · doi:10.1007/s00213-018-5153-8 · Cited by 27
Seemiller, L. R., Flores-Cuadra, J. A., Griffith, K. R., Smith, G. C., & Crowley, N. A. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100605 · Cited by 27
“Importantly, following alcohol withdrawal, cytokine levels can also heighten during negative emotional states (Breese et al., 2008).”
BackgroundGrodin, E. N., Nieto, S. J., Meredith, L. R., Burnette, E., O'Neill, J., Alger, J., London, E. D., Miotto, K., Evans, C. J., Irwin, M. R., et al. (2022) · Addiction Biology · doi:10.1111/adb.13182 · Cited by 25
The Neuroimmune Transcriptome and Alcohol Dependence: Potential for Targeted Therapies
Warden, A. S., Erickson, E. K., Robinson, G., Harris, R. A., & Mayfield, R. D. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0062 · Cited by 31
Varodayan, F. P., Khom, S., Patel, R. R., Steinman, M. Q., Hedges, D. M., Oleata, C. S., Homanics, G. E., Roberto, M., & Bajo, M. (2018) · Alcohol and Alcoholism · doi:10.1093/alcalc/agx114 · Cited by 24
Sickness behavior is accentuated in rats with metabolic disorders induced by a fructose diet
Orlandi, L., Fonseca, W. F., Enes-Marques, S., Paffaro, V. A., Vilela, F. C., & Giusti‐Paiva, A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.10.014 · Cited by 25
“These time points were chosen on the basis of previous behavioral, endocrine and neurochemical studies (Breese et al., 2008).”
Chang, G., Karatayev, O., Boorgu, D. S. S. K., & LEIBOWITZ, S. F. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.10.013 · Cited by 20
O’Sullivan, S. J., & Schwaber, J. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.033 · Cited by 23
Harper, K. M., Knapp, D. J., & Breese, G. R. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12898 · Cited by 21
Self-citationNeuroimaging of inflammation in alcohol use disorder: a review
Feldman, D. E., McPherson, K. L., Biesecker, C. L., Wiers, C. E., Manza, P., Volkow, N. D., & Wang, G. (2020) · Science China Information Sciences · doi:10.1007/s11432-019-2857-5 · Cited by 22
The Significance of Toll-Like Receptors in the Neuroimmunologic Background of Alcohol Dependence
Czerwińska-Błaszczyk, A., Pawlak, E., & Pawłowski, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.797123 · Cited by 26
Richey, L., Doremus‐Fitzwater, T. L., Buck, H. M., & Deak, T. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.004 · Cited by 19
Ming, Z., Criswell, H. E., & Breese, G. R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.06.001 · Cited by 23
Self-citationBreese, G. R., & Knapp, D. J. (2016) · Alcohol · doi:10.1016/j.alcohol.2016.01.005 · Cited by 19
Self-citationInvolvement of TOLL-like receptors in the neuroimmunology of alcoholism
Airapetov, M. I., Eresko, S. O., Aa, L., Бычков, Э. Р., & Shabanov, P. D. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206603208 · Cited by 14
Harper, K. M., Knapp, D. J., Park, M. A., & Breese, G. R. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4439-y · Cited by 16
Self-citationNeuroimmune Mechanisms of Glia and Their Interplay with Alcohol Exposure Across the Lifespan
Drew, P. D., & Kane, C. J. M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_11 · Cited by 12
“Furthermore, cytokines were demonstrated to contribute to alcohol withdrawal-induced anxiety behavior [ 129 ] .”
BackgroundCocaine counteracts LPS-induced hypolocomotion and triggers locomotor sensitization expression
Tortorelli, L. S., Engelke, D. S., Lunardi, P. S., Souza, T. M. E., Santos-Junior, J. G., & Gonçalves, C. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.054 · Cited by 14
Hagerty, S. L., Ellingson, J. M., Helmuth, T. B., Bidwell, L. C., Hutchison, K. E., & Bryan, A. D. (2019) · Perspectives on Psychological Science · doi:10.1177/1745691619827010 · Cited by 12
Knapp, D. J., Harper, K. M., Melton, J., & Breese, G. R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.015 · Cited by 10
Self-citationDeak, T., Okrainets, A., & Doremus‐Fitzwater, T. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_5 · Cited by 12
Mason, B. J., Estey, D., Roberts, A. J., de Guglielmo, G., George, O., Light, J. M., Stoolmiller, M., Quello, S. B., Skinner, M., Shadan, F. F., et al. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100604 · Cited by 10
Harper, K. M., Knapp, D. J., Park, M. A., & Breese, G. R. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.03.007 · Cited by 9
Self-citationCCL2-ethanol interactions and hippocampal synaptic protein expression in a transgenic mouse model
Gruol, D. L., Vo, K., Bray, J. G., & Roberts, A. J. (2014) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2014.00029 · Cited by 9
Are the effects of alcohol on the CNS influenced by Toll-like receptor signaling?
Corrigan, F., & Hutchinson, M. R. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.99 · Cited by 7
Ahangar, N., Esam, Z., Bekhradnia, A., & Ebrahimzadeh, M. A. (2016) · PubMed Central · Cited by 6
Inflammatory mechanisms of abused drugs
Mitchell, C. M., Jordi, O. E., & Yamamoto, B. K. (2018) · Advances in neurotoxicology · doi:10.1016/bs.ant.2018.10.006 · Cited by 6
Airapetov, M. I., Eresko, S. O., Aa, L., Бычков, Э. Р., & Shabanov, P. D. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196505380 · Cited by 4
Neurobiology of negative reinforcement as a driving force in alcohol addiction
Vendruscolo, L. F., & Koob, G. F. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.038 · Cited by 5
Diaz, M. R., Barney, T. M., Marsland, P., & Deak, T. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110304 · Cited by 3
The Mental Burden of Immunoperception
Saghazadeh, A., Hafizi, S., & Rezaei, N. (2019) · Springer eBooks · doi:10.1007/978-3-030-10620-1_9 · Cited by 3
Monnig, M. A., Lamb, P. S., Clark, S. E., & Monti, P. M. (2025) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.70106 · Cited by 3
McNair, E. M., Dawkins, L., Materia, B. R., Ross, G., Barnett, A., Nakkala, P., Qin, L., Zou, J., Nikolova, V. D., Moy, S. S., et al. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.10.005 · Cited by 5
“Proin-flammatory cytokines are associated with stress and anxiety-like behavior, 32,33 whereas brain-derived neurotrophic factor (BDNF) signaling, an anti-inflammatory/ trophic mediator, reduces alcohol-induced anxiety-like behavior in stress regions.”
Alcohol–Chemokine Interaction and Neurotransmission
Gruol, D. L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_12 · Cited by 2
Peroxisome Proliferator-Activated Nuclear Receptors and Drug Addiction
Mascia, P., Tanda, G., Yaşar, S., Heishman, S. J., & Goldberg, S. R. (2012) · The Receptors · doi:10.1007/978-1-4614-4669-9_11 · Cited by 3
Role of Toll-Like Receptor 4 in Alcohol-Induced Neuroinflammation and Behavioral Dysfunctions
Guerri, C., & Pascual, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_9 · Cited by 4
Meda, S. A., Narayanan, B., Chorlian, D. B., Meyers, J. L., Gelernter, J. E., HESSELBROCK, V. M., Bauer, L. O., Calhoun, V. D., Porjesz, B., & Pearlson, G. D. (2019) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14063 · Cited by 2
The Role of Toll-Like Receptors in Neuroimmunology of Alcoholism
Airapetov, M. I., Eresko, S. O., Aa, L., Бычков, Э. Р., & Shabanov, P. D. (2021) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750821010029 · Cited by 2
Airapetov, M. I., Eresko, S. O., Aa, L., Бычков, Э. Р., & Shabanov, P. D. (2020) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750820010023 · Cited by 2
Innate Immune Signaling and Alcoholism
Vetreno, R. P., & Crews, F. T. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_8 · Cited by 2
The Molecular Neurobiology of Addiction
Marrocu, A., Giacobbe, J., Pariante, C. M., & Borsini, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00084-0 · Cited by 2
Airapetov, M. I., Eresko, S. O., Vasil'ev, A. K., Vasileva, V. Y., Бычков, Э. Р., Aa, L., & Shabanov, P. D. (2021) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20216704331 · Cited by 1
Interleukin-1β and TNF-α are elevated in the amygdala of adult rats prenatally exposed to ethanol
Kokhan, V. S., Anokhin, P. K., Proskuryakova, T. V., Shokhonova, V. A., Андреевич, А. Р., & Shamakina, I. Y. (2023) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20236905300 · Cited by 2
Mahdizadeh, M., Kakhki, S., Tafti, S. P., Khatibi, S. A., Kaffashan, F., & Beheshti, F. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42752 · Cited by 1
Ibrahim, K. M., Ahmed, H. I., Ramadan, L. A. A., & Balah, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05854-4 · Cited by 1
Neuroimaging and Clinical Studies on Brain–Immune Interactions
Hannestad, J. O. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_4 · Cited by 1
Neuroimmune consequences of chronic alcohol exposure: relationship to stress
Whitman, B. A. (2012) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/0ppt-7f35 · Cited by 1
Metadata
- Authors
- Breese, G. R., Knapp, D. J., Overstreet, D. H., Navarro, M., Wills, T. A., & Angel, R. A.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Breese, George R
- Venue
- Neuropsychopharmacology
- Published
- 2007-06-06
- Volume
- 33
- Issue
- 4
- Pages
- 867-876
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC2268634
- OpenAlex
- W2023536806
- Cited by
- 110
- References
- 90
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 4 · 2021: 11 · 2020: 7 · 2019: 12 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 6 · 2014: 3 · 2013: 4 · 2012: 11
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Update notices
- erratum (2008-05-13)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institute on Alcohol Abuse and Alcoholism (F31AA016704, R01AA014284, P50AA011605, AA 11605, R01AA014949, AA16704, R01AA012655, NIAAA‐AA11605, AA 14949, AA 007573, AA014284, AA-12655, P60AA011605, T32AA007573)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- ethanol withdrawal, anxiety-like behavior, lipopolysaccharide, cytokines, TNF-α, IL-1β, CCL2/MCP-1, flumazenil, benzodiazepine receptor, GABAA receptor, stress, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Ethanol, Analysis of Variance, Animals, Antidotes, Anxiety, Behavior, Animal, Body Weight, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Flumazenil, Interpersonal Relations, Lipopolysaccharides, Male, Motor Activity, Substance Withdrawal Syndrome, Time Factors, Cytokines, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.